For PSA glycans, higher levels of α2,3-linked sialylation are found in patients with high-risk prostate cancer [42], while for AFP glycosylation, the level of core fucosylation is positively associated with the occurrence of hepatocellular carcinoma and its progression [43]. This evidence concerns the gene KLK3 and prostate carcinoma.